Withdrawn NCT05956600
This study was withdrawn. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries
Sponsor University of California, Los Angeles
Condition Schizophrenia Completed NCT04298450
This summary needs review. Please check the official study record and contact the research team for details.
In Toronto Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity, ... Behavioral From 16 Years to 29 Years
Countries Canada
Sponsor Centre for Addiction and Mental Health
Condition Schizophrenia, Bipolarity, ... Completed NCT07371325
This study is completed in Spain. It focuses on schizophrenia.
In Pamplona Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries Spain
Sponsor Manuel Jesús Cuesta Zurita
Condition Schizophrenia Completed NCT02627716
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Brest Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other From 18 Years to 65 Years
Countries France
Sponsor University Hospital, Lille
Condition Schizophrenia Completed NCT05784948
This summary needs review. Please check the official study record and contact the research team for details.
In Jeonju Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 15 Years to 59 Years
Countries South Korea
Sponsor Chonbuk National University Hospital
Condition Schizophrenia Completed NCT04779177
This study is completed in the United States. It is testing lumateperone for schizophrenia.
Multiple locations, including Hollywood Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 13 Years to 17 Years
Countries United States
Sponsor Intra-Cellular Therapies, Inc.
Condition Schizophrenia Terminated NCT00581243
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 50 Years
Countries
Sponsor Wyeth is now a wholly owned subsidiary of Pfizer
Condition Schizophrenia Completed NCT07043803
This study is looking at whether a digital support tool can help people with Schizophenia Disorder, schizoaffective disorder, or bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.
Multiple locations, including Altoona Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity Other Over 18 Years
Countries United States
Sponsor University of Pittsburgh
Condition Schizophrenia, Bipolarity Not recruiting ISRCTN68736636
This study is not recruiting in France, in Switzerland, in Belgium, .... It focuses on schizophrenia.
In Austria Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other Over 18 Years
Countries France, Switzerland, Belgium, ...
Sponsor European Group for Research in Schizophrenia (EGRIS) (Austria)
Condition Schizophrenia Not recruiting ISRCTN45593573
This study is looking at care and outcomes for people with Late onset schizophrenia like psychosis, Mental and Behavioural Disorders, or Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In United Kingdom Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Other
Countries United Kingdom
Sponsor Kings College London (UK)
Condition Schizophrenia Completed NCT02006628
This study is completed in the United Kingdom, in Poland, and in Romania. It is testing GWP42003 for schizophrenia.
Multiple locations, including Czeladź Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United Kingdom, Poland, Romania
Sponsor Jazz Pharmaceuticals
Condition Schizophrenia Completed NCT03730831
This summary needs review. Please check the official study record and contact the research team for details.
In Konstanz Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, PTSD Behavioral From 18 Years to 65 Years
Countries Germany
Sponsor University of Konstanz
Condition Schizophrenia, PTSD